Abetalipoproteinemia (ABL) is a rare disease, characterized by absence or very low apoB-containing lipoproteins in plasma and remarkable hepatic steatosis or cirrhosis, which is attributable to decreased lipid secretion from the liver and caused by MTTP gene mutation [3, 4]. Here, APOB is linked to fatty liver disease.